126 related articles for article (PubMed ID: 26320856)
1. TAB3 involves in hepatic insulin resistance through activation of MAPK pathway.
Zhao Y; Tang Z; Zhu X; Wang X; Wang C; Zhang W; Xia N; Wang S; Huang J; Cui S
Gen Comp Endocrinol; 2015 Dec; 224():228-34. PubMed ID: 26320856
[TBL] [Abstract][Full Text] [Related]
2. Roles for TAB1 in regulating the IL-1-dependent phosphorylation of the TAB3 regulatory subunit and activity of the TAK1 complex.
Mendoza H; Campbell DG; Burness K; Hastie J; Ronkina N; Shim JH; Arthur JS; Davis RJ; Gaestel M; Johnson GL; Ghosh S; Cohen P
Biochem J; 2008 Feb; 409(3):711-22. PubMed ID: 18021073
[TBL] [Abstract][Full Text] [Related]
3. TAK1-dependent signaling requires functional interaction with TAB2/TAB3.
Besse A; Lamothe B; Campos AD; Webster WK; Maddineni U; Lin SC; Wu H; Darnay BG
J Biol Chem; 2007 Feb; 282(6):3918-28. PubMed ID: 17158449
[TBL] [Abstract][Full Text] [Related]
4. TAB3, a new binding partner of the protein kinase TAK1.
Cheung PC; Nebreda AR; Cohen P
Biochem J; 2004 Feb; 378(Pt 1):27-34. PubMed ID: 14670075
[TBL] [Abstract][Full Text] [Related]
5. Role of Mig-6 in hepatic glucose metabolism.
Yoo JY; Kim TH; Kong S; Lee JH; Choi W; Kim KS; Kim HJ; Jeong JW; Ku BJ
J Diabetes; 2016 Jan; 8(1):86-97. PubMed ID: 25594850
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of the P-glycoprotein relevant for multidrug resistance by intracellular acidification through the crosstalk of MAPK signaling pathways.
Jin W; Lu Y; Li Q; Wang J; Zhang H; Chang G; Lin Y; Pang T
Int J Biochem Cell Biol; 2014 Sep; 54():111-21. PubMed ID: 25043687
[TBL] [Abstract][Full Text] [Related]
7. Prolonged treatment of primary hepatocytes with oleate induces insulin resistance through p38 mitogen-activated protein kinase.
Liu HY; Collins QF; Xiong Y; Moukdar F; Lupo EG; Liu Z; Cao W
J Biol Chem; 2007 May; 282(19):14205-12. PubMed ID: 17384440
[TBL] [Abstract][Full Text] [Related]
8. Polyubiquitination of Transforming Growth Factor β-activated Kinase 1 (TAK1) at Lysine 562 Residue Regulates TLR4-mediated JNK and p38 MAPK Activation.
Chen IT; Hsu PH; Hsu WC; Chen NJ; Tseng PH
Sci Rep; 2015 Jul; 5():12300. PubMed ID: 26189595
[TBL] [Abstract][Full Text] [Related]
9. Cross interference with TNF-alpha-induced TAK1 activation via EGFR-mediated p38 phosphorylation of TAK1-binding protein 1.
Shin MS; Shinghirunnusorn P; Sugishima Y; Nishimura M; Suzuki S; Koizumi K; Saiki I; Sakurai H
Biochim Biophys Acta; 2009 Jul; 1793(7):1156-64. PubMed ID: 19393267
[TBL] [Abstract][Full Text] [Related]
10. G protein-coupled receptors activate p38 MAPK via a non-canonical TAB1-TAB2- and TAB1-TAB3-dependent pathway in endothelial cells.
Grimsey NJ; Lin Y; Narala R; Rada CC; Mejia-Pena H; Trejo J
J Biol Chem; 2019 Apr; 294(15):5867-5878. PubMed ID: 30760523
[TBL] [Abstract][Full Text] [Related]
11. TRAF6 promotes myogenic differentiation via the TAK1/p38 mitogen-activated protein kinase and Akt pathways.
Xiao F; Wang H; Fu X; Li Y; Wu Z
PLoS One; 2012; 7(4):e34081. PubMed ID: 22496778
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta-activated kinase 1 and TAK1-binding protein 1 cooperate to mediate TGF-beta1-induced MKK3-p38 MAPK activation and stimulation of type I collagen.
Kim SI; Kwak JH; Zachariah M; He Y; Wang L; Choi ME
Am J Physiol Renal Physiol; 2007 May; 292(5):F1471-8. PubMed ID: 17299140
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts.
Gu J; Liu X; Wang QX; Tan HW; Guo M; Jiang WF; Zhou L
Exp Cell Res; 2012 Oct; 318(16):2105-15. PubMed ID: 22749815
[TBL] [Abstract][Full Text] [Related]
14. PRDX1 is involved in palmitate induced insulin resistance via regulating the activity of p38MAPK in HepG2 cells.
Tang Z; Xia N; Yuan X; Zhu X; Xu G; Cui S; Zhang T; Zhang W; Zhao Y; Wang S; Shi B
Biochem Biophys Res Commun; 2015 Oct; 465(4):670-7. PubMed ID: 26301632
[TBL] [Abstract][Full Text] [Related]
15. Targeting DUSP16/TAK1 signaling alleviates hepatic dyslipidemia and inflammation in high fat diet (HFD)-challenged mice through suppressing JNK MAPK.
Wu YK; Hu LF; Lou DS; Wang BC; Tan J
Biochem Biophys Res Commun; 2020 Mar; 524(1):142-149. PubMed ID: 31982140
[TBL] [Abstract][Full Text] [Related]
16. P53 modulates hepatic insulin sensitivity through NF-κB and p38/ERK MAPK pathways.
Geng S; Zhu W; Wang S; Xie C; Li X; Wu J; Li Y; Chen Y; Wang X; Meng Y; Zhang Q; Chen J; Zhong C
Biochem Biophys Res Commun; 2018 Jan; 495(3):2139-2144. PubMed ID: 29258820
[TBL] [Abstract][Full Text] [Related]
17. Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle.
Jung TW; Chung YH; Kim HC; Abd El-Aty AM; Jeong JH
Mol Cell Endocrinol; 2018 Jul; 470():26-33. PubMed ID: 29111387
[TBL] [Abstract][Full Text] [Related]
18. Smad6 inhibits non-canonical TGF-β1 signalling by recruiting the deubiquitinase A20 to TRAF6.
Jung SM; Lee JH; Park J; Oh YS; Lee SK; Park JS; Lee YS; Kim JH; Lee JY; Bae YS; Koo SH; Kim SJ; Park SH
Nat Commun; 2013; 4():2562. PubMed ID: 24096742
[TBL] [Abstract][Full Text] [Related]
19. Dual-specificity phosphatase 14 (DUSP14/MKP6) negatively regulates TCR signaling by inhibiting TAB1 activation.
Yang CY; Li JP; Chiu LL; Lan JL; Chen DY; Chuang HC; Huang CY; Tan TH
J Immunol; 2014 Feb; 192(4):1547-57. PubMed ID: 24403530
[TBL] [Abstract][Full Text] [Related]
20. TAB3 upregulates PIM1 expression by directly activating the TAK1-STAT3 complex to promote colorectal cancer growth.
Li Q; Chen L; Luo C; ChenYan ; Ge J; Zhu Z; Wang K; Yu X; Lei J; Liu T; Peng X; Liu X; Yuan R
Exp Cell Res; 2020 Jun; 391(1):111975. PubMed ID: 32229191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
